You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

ATIVAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ativan, and what generic alternatives are available?

Ativan is a drug marketed by Hikma and Bausch and is included in two NDAs.

The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ativan

A generic version of ATIVAN was approved as lorazepam by SANDOZ on April 21st, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ATIVAN?
  • What are the global sales for ATIVAN?
  • What is Average Wholesale Price for ATIVAN?
Summary for ATIVAN
Drug patent expirations by year for ATIVAN
Drug Prices for ATIVAN

See drug prices for ATIVAN

Drug Sales Revenue Trends for ATIVAN

See drug sales revenues for ATIVAN

Recent Clinical Trials for ATIVAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
California Institute of TechnologyPhase 4
Laureate Institute for Brain Research, Inc.Phase 4
Temple UniversityPhase 4

See all ATIVAN clinical trials

Pharmacology for ATIVAN
Drug ClassBenzodiazepine

US Patents and Regulatory Information for ATIVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ATIVAN lorazepam TABLET;ORAL 017794-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ATIVAN lorazepam TABLET;ORAL 017794-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch ATIVAN lorazepam TABLET;ORAL 017794-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ATIVAN

See the table below for patents covering ATIVAN around the world.

Country Patent Number Title Estimated Expiration
Belgium 794224 ⤷  Sign Up
Australia 5024072 ⤷  Sign Up
Ireland 38298 PARENTERAL BENZODIAZEPINE COMPOSITIONS ⤷  Sign Up
France 2181679 ⤷  Sign Up
United Kingdom 1345510 ⤷  Sign Up
Australia 461715 ⤷  Sign Up
Netherlands 7300694 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.